Baxter International

From 9/11 Encyclopedia:

Baxter, a global health care company, is the leading maker of intravenous (IV) supplies and solutions via its Medication Delivery unit, which brings in almost 40% of sales. Baxter is the leading U.S. provider of cardiovascular, kidney dialysis, and intravenous products to the healthcare market. "Blood goes in, blood goes out, and Baxter International is there. Through its BioScience segment, the company not only makes equipment to collect and separate blood and blood components, but also develops plasma protein therapies for such blood-related disorders as hemophilia" http://www.hoovers.com/co/capsule/8/0,2163,10188,00.html 

In 1979 Baxter introduced the first automated blood-cell separator, the CS-3000 system. In 1985 they acquired American Hospital Supply Corporation. In 1995 Nextran became a wholly owned affiliate of Baxter, focusing on research in xenotransplantation, or animal-to-human transplants. In 1997 Baxter acquired Immuno International AG, an international leader in infectious disease research and the development of blood products, related biologics and vaccines. In the same year, Baxter, Becton Dickinson and Johns Hopkins University (->) filed together a lawsuit on a stem cell patent by CellPro, Inc. http://www.baxter.com/utilities/news/releases/1997/04-08Cellpro.html 

Baxter is behind Global Healthcare Exchange, an independent, Internet-based company that facilitates the exchange of information related to buying, selling and distributing medical equipment, devices and healthcare products and related services worldwide. 

To improve their research on blood related products, their subsidiary Baxter Healthcare supports cruel experiments on animals, too. One of these financed tortures are the so called AHA Experiments on 2 days to 8 weeks old dogs, in which they are subjected to hosting a chronic indwelling catheter for 30 days. 
Two pain medications are being delivered through these catheters to assess their toxicological effects. 
The experiments take place at the University of Arizona, Tucson. Source: http://216.239.37.100/search?q=cache:C9lBMfQ-5l8C:www.uofazkillsdogs.com/research.htm+AHA+Experiments&hl=en&ie=UTF-8

In late 2001, Baxter announced that it would participate in the production of approximately 155 million doses of smallpox vaccine (->) , in conjunction with Acambis Inc (->, former Oravax). Source: http://www.baxter.com/investors/profile/history/index.html

(-> 9/11-Anthrax Gate, Nanosphere) (See Smallpox Vaccines)